Neptune Rises Again



Recently I presented at Rodman & Renshaw 16th Annual Global Investment Conference, and I’m excited to share our thoughts with everyone as Neptune moves forward toward SupplySide West and into 2015.


Everyone within the industry knows the challenges we’ve had over the past year, but 2014 is our comeback year in which Neptune is executing several strategies to reestablish our leadership position in the marketplace after losing our production facility in a 2012 tragedy.


While the new plant was under construction, Neptune was able to enforce our intellectual property to protect our investment; as an example we granted licenses to three competitors to sell krill oil, bearing one time settlements and royalty agreements.


We reopened the plant this past June and expect to reach full operational capacity of 150 metric tons annually in October/November of this year. We’ve signed a third-party agreement to expand production and diversify our production model to limit risk and developed three new formulations, each featuring NKO®.


On the corporate side we refreshed the Board of Directors , introduced a new management team, supported subsidiaries in the development of pharmaceutical grade Omega-3 products targeting cardio-metabolic and neurological conditions, and developed strong global partnerships with plans to expand our customer base in both our current and new territories, including the US, China and South America.


Our team is very excited about the future with our current and new partners and looks forward to a great SupplySide West show and a fantastic 2015.


If you’d like to see my presentation, CLICK HERE.



About the Author



Mr. André Godin, C.P.A. has more than 20 years’ experience in the Biotech/Pharma industry as former president of a dietary supplement company and as a corporate controller for a pharmaceutical company in OTC products. Mr. Godin is currently the acting interim President and Chief Executive Officer.